Intelerad’s Post

Comprehension in dermatology is realized through visual communication. Without it there is chaos. Battles for our patients will continue if we only put out fires created by delayed diagnosis. The WAR ON SKIN CANCER will be won when we prioritize preventative medicine. This begins with dermoscopy. #skincancer #melanoma #digitalhealth #artificialintelligence #ai

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment : In this Dermatology Times article, listen to Christopher Bunick, MD, PhD, as he delves into current data and guidelines to consider when creating custom treatment plans for patients with atopic dermatitis. https://lnkd.in/gsDAMw86

Rocco Serrao, MD, found his expertise in inflammation, particularly #psoriasis. He delved into the promising data on #bimekizumab at Maui Dermatology NP+PA Fall 2023, shedding light on its potential to block key signaling pathways and achieve impressive PASI scores in phase 3 trials. #DermatologyInnovation #PsoriasisSolutions 🌟🔬 https://lnkd.in/gX3ygCXx

Want to learn more about our AtopicDermatitis registry. Let’s schedule a meeting and discuss how we can support your dermatology development initiatives. #rwe #rwd #registry #atopicdermatitis

Journal of Dermatology for NPs & PAs co-founder and editor Douglas DiRuggiero, DMSc, MHS, PA-C, talks to Raj Chovatiya, MD, PhD, MSCI, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, IL, about how and why to encourage non-segmental #vitiligo patients to stick with daily application of ruxolitinib cream 1.5% (Opzelura, Incyte). They also discuss how this cream repigments multiple body parts in vitiligo and share tips on the best ways to address patient safety concerns. https://lnkd.in/dqhr7RW9

At the end of #AAD2024, Andrew Alexis, MD, MPH, vice-chair for diversity and inclusion for the department of dermatology and professor of clinical dermatology at Weill Cornell Medicine, discussed the significance of new tapinarof cream findings as they relate to the current state of clinical management of atopic dermatitis skin of color. Alexis additionally talked about what specific clinical and demographic challenges patients of color face in adequately treating chronic skin diseases, and what further steps may his peers take to further improve representation in research and care tailored to skin of color. Read here: https://lnkd.in/e_uCYy4M

Did you know that, according to The American Cancer Society, about 97,610 new melanomas will be diagnosed and about 7,990 people are expected to die of melanoma in 2023? This #MelanomaAwarenessMonth, Mass General Brigham’s Chief Data Science Officer, Dr. Keith J. Dreyer, sits down with Dr. David Fisher, Chairman of Mass General Hospital’s Dermatology Department, to discuss the impact #AI could have when diagnosing skin malignancies. Watch the video below to learn how AI can help diagnose melanomas and the potential roadblocks healthcare systems might run into when developing this new technology. Watch video on YouTube here: https://lnkd.in/eB_G3s5K Watch past Coffee with Keith episodes here: https://lnkd.in/eivNMkzu #ArtificialIntelligence #Dermatology

Yesterday I was invited to share our recently published original results on the intriguing relationship of: ➡️Psoriasis / Atherosclerosis / Liver Disease ➡️If you want to know more about this complex triangle check out our paper published in the Journal of Investigative Dermatology with Joel M Gelfand MD MSCE Nehal Mehta: https://lnkd.in/dSYiqQn #Psoriasis #comorbidities #research

New article via Dermatology Times: Researchers examined the effect of the DecisionDx-Melanoma 31-gene expression profile (31-GEP) test on survival outcomes. Findings showed that patients with 31-GEP testing had a 29% lower melanoma-specific survival mortality and a 17% lower overall mortality than patients who did not have the test. Full article: https://hubs.la/Q01_wp6z0 #DecisionDx #Melanoma #GEP

This week’s quiz. (Hint below) -https://lnkd.in/etY9xCqQ : Ask anything in Dermatology while at World Psychodermtology Day. Hint: Of historical interest: The term was first coined in 1664 by a Polish physician J.Jonston “Medicina Practica". *Program Highlights: -Patient perspectives, Panel discussions and Presentations -Psychiatric Diseases in Dermatology -Mental Health in Chronic Dermatoses (Acne, Alopecia Areata, Hidradenitis Suppurativa, Psoriasis, Vitiligo) -Psychodermatology in Cosmetic Dermatology -Psychodermatology around the World